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Abstract
Background: Dystocia, difficult labour, is a common but also complex problem during childbirth. It can be attributed 
to either weak contractions of the uterus, a large infant, reduced capacity of the pelvis or combinations of these. 
Previous studies have indicated that there is a genetic component in the susceptibility of experiencing dystocia. The 
purpose of this study was to identify susceptibility genes in dystocia.
Methods: A total of 104 women in 47 families were included where at least two sisters had undergone caesarean 
section at a gestational length of 286 days or more at their first delivery. Study of medical records and a telephone 
interview was performed to identify subjects with dystocia. Whole-genome scanning using Affymetrix genotyping-
arrays and non-parametric linkage (NPL) analysis was made in 39 women exhibiting the phenotype of dystocia from 19 
families. In 68 women re-sequencing was performed of candidate genes showing suggestive linkage: oxytocin (OXT) 
on chromosome 20 and oxytocin-receptor (OXTR) on chromosome 3.
Results: We found a trend towards linkage with suggestive NPL-score (3.15) on chromosome 12p12. Suggestive 
linkage peaks were observed on chromosomes 3, 4, 6, 10, 20. Re-sequencing of OXT and OXTR did not reveal any 
causal variants.
Conclusions: Dystocia is likely to have a genetic component with variations in multiple genes affecting the patient 
outcome. We found 6 loci that could be re-evaluated in larger patient cohorts.
Background
Dystocia, defined as prolonged and difficult labour, is a
common obstetric problem affecting 6-8% of all deliveries
[1]. It is a major global health problem due to the
increased risk of intrauterine asphyxia of the fetus, opera-
tive delivery and subsequently increased risk of both fetal
and maternal morbidity such as haemorrhage, infections,
pelvic floor trauma, subsequent placenta accreta and
neurological disabilities [2-5]. Dystocia followed by
instrumental delivery or caesarean section might also be
major psychological trauma leading to increased levels of
anxiety that by some authors even has been classified as
post traumatic stress disorder [6,7].
Parturition is regulated by many factors and the mecha-
nisms regulating labour and the expulsion of the child are
incompletely understood [8]. Animal studies have shown
that knock-out mice models of genes regulating parturi-
tion exhibit dystocia [9,10], but this has not yet been
shown in humans [11]. A strong genetic influence has
been shown in other obstetric conditions such as preec-
lampsia, low birth weight, and abnormal gestational
length [12,13]. Studies have also detected an increased
risk for dystocia in a woman with affected mother or sis-
ter [14,15]. We have previously estimated the heritability
of dystocia to be 28% [16] and this finding has encour-
aged us to perform a genome-wide scan in a material
consisting of affected sib pairs to further assess the
genetic basis for dystocia.
Methods
Study population
We used the Swedish Medical Birth Registry [17] that
covers almost all births in Sweden to identify women who
had given their first birth with caesarean section between
1982 and 1997 at a gestational length of more than 286
days. The reason for this was to have a well defined end
point and to increase the chance of finding subjects with
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dystocia since this condition is more frequent in primipa-
ras and in prolonged gestation and a majority of operative
deliveries after 41 weeks are emergency caesarean sec-
tions. Using the Swedish Multigeneration Registry [18]
we managed to connect 75 sister pairs where both sib-
lings fulfilled the above-mentioned criteria and subse-
quently contacted them for inclusion in the study. One of
the investigators (M. Algovik) performed a structured
telephone interview with all women to verify their eligi-
bility to participate in the study, and to investigate
whether their mothers had experienced problems giving
birth or if there were any other close relatives with such
problems. The telephone interview also included ques-
tions about the women's subsequent obstetric history and
their current health status. To be able to make a simple
evaluation of the women's overall experience of the deliv-
ery they were also asked to grade it on a five-step scale
from very bad to very good. All participants gave their
written consent to participate in the study and permis-
sion to review the medical records from their first deliv-
ery. The diagnosis was confirmed by study of the medical
charts of the delivery including partogram. Women with
breech presentation, contracted pelvis (sum of the pelvic
diameters < 29.5 cm) or a child weighing more than 5000
g were not included in the genetic analysis (NPL). Simi-
larly, multiple pregnancies and families where one or
more members refused to participate were excluded.
Following the telephone interviews and the study of the
medical records we concluded that the phenotype is het-
erogeneous since not all of the women had dystocia as an
indication for their caesarean section. Given that the pri-
mary focus of the study was uterine dysfunction rather
than other reasons for dystocia and to enable us to pick
the affected sib pairs with the most uniform phenotype
for genetic analysis we divided the diagnosis of dystocia
into four subgroups: certain dystocia, likely dystocia,
unlikely dystocia and no dystocia. These subgroups are
described below:
1. Certain dystocia: Definite diagnosis (see Table 1), 
all subsequent deliveries by caesarean section without 
other indications.
2. Likely dystocia: Induction of labour, long delivery 
time (> 20 h), all subsequent deliveries by caesarean 
section or instrumental delivery and no other indica-
tions.
3. Unlikely dystocia: No induction of labour, short 
delivery time (< 20 h), other indication for caesarean 
i.e. relative disproportion, child ≥ 5000 g, subsequent 
deliveries without caesarean section or instrumental 
delivery.
4. No dystocia: Absolute disproportion, breech pre-
sentation, caesarean section before start of labour, 
delivery misclassified as caesarean but was actually 
vaginal.
Additional sisters and cousins were invited to partici-
pate in families where several women were identified
with delivery-related problems. Of the initial 150 women,
56 were excluded and 10 new cases added making the
study population a total of 104. Of these 104 women, 83
provided a blood sample for the genetic analysis. Only
families with women in group 1 and 2 were used in the
genetic analysis with non-parametric linkage (NPL). See
Table 2 for details regarding the study population. The
study protocol was approved by the institutional review
board at Karolinska University Hospital, Huddinge, Swe-
den.
Genotyping and genetic analysis
Single nucleotide polymorphism (SNP) genotyping was
performed for 18 affected sib-pairs and one family with
three affected siblings using the Affymetrix GeneChip®
Mapping 10 K 2.0 array containing approximately 10,000
SNP markers following the manufacturer's instructions
(Affymetrix, Santa Clara, CA, USA).
MERLIN [19] was used to calculate the Whittemore
and Halpern non-parametric linkage (NPL) scores [20].
NPL is a way of measuring how often certain genetic
areas are inherited together. Marker positions on
DECODE genetic map were retrieved from Affymetrix
using NetAffx™ [21], and allele frequencies were esti-
mated using Caucasian allele frequencies provided by
Affymetrix. We had low power to detect genotyping
errors due to study design, but MERLIN flagged 124 gen-
otypes as unlikely and these were removed from linkage
analysis. All individuals were analyzed as affected. NPL
scores were calculated for all families, and graphs were
created using GNUPLOT. In the graphs, x-axis represents
the DECODE genetic map locus, and y-axis represents
the NPL score. Genome-wide and chromosome-wide sig-
nificance of NPL-scores was estimated by simulating data
1,000 times with Merlin and extracting the highest NPL-
Table 1: Diagnose codes
Diagnose code Text ICD revision Year
657.0, 657.1 Prolonged labour, primary and secondary ICD-8 1973-1986
661A-C, 662A-C Primary and secondary dystocia ICD-9 1987-1996
O62.0-1, O63.0-1 Primary and secondary dystocia ICD-10 1996-Algovik et al. BMC Medical Genetics 2010, 11:105
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score from each simulation. Physical positions of peak
regions were verified manually against the NCBI dbSNP
build 126, which gives chromosomal coordinates for
human genome build 36.
Re-sequencing
Genomic DNA from 68 affected individuals with dystocia
and a historic reference material consisting of 107 healthy
women without adverse obstetric history who had given a
written consent to participate in studies on complications
of pregnancy were used to sequence oxytocin (OXT) and
oxytocin receptor (OXTR) genes. Cases were not
matched with the reference group, but were used to
establish an estimate of the population frequency of
potential mutations. Exons including 100 bp flanking
sequence on both sides and 1 kb upstream of the first
exon were amplified using polymerase chain reaction
(PCR). Purified PCR products were sequenced using
DYEnamic ET dye terminator kit following manufac-
turer's instructions (Amersham Biosciences, Bucking-
hamshire, UK) and electrophoresed using a MegaBACE
1000 instrument (Amersham Biosciences, Uppsala, Swe-
den). Sequence analysis was performed using the
MegaBACE Sequence Analyser 3.0 software (Amersham
Biosciences) and Staden package computer programs
[22].
Results
Characteristics of the study population
We identified 76 women (73.1%) exhibiting a phenotype
of certain or likely dystocia. Since many of the subjects
were post-term, 53 (51.0%) of them had undergone
induction of labour. In 16 of the 47 families (34.0%), the
mother had had dystocia or some other obstetric problem
such as instrumental or breech delivery. Thirty-eight
(36.5%) women said that the delivery had been a bad or
very bad experience and 22 (21.2%) said that their first
delivery had negatively influenced the number of children
they had born. Clinical characteristics have been col-
lected in Table 3 for all interviewed women, Table 4 for
the affected sib pairs included in the genetic analysis
(NPL) and Table 5 for the 68 women that were used for
the re-sequencing of OXT  and OXTR. Since additional
female relatives were included after the initial selection to
create complete pedigrees some of these values differ
from the original selection criteria.
Genetic analysis, non-parametric linkage (NPL)
According to simulations performed with Merlin, signifi-
cant P-value (identified by an NPL-score reached in 5% of
simulations) would have corresponded to an NPL-score
of 3.64, while suggestive P-value (identified by an NPL-
score reached at least once per simulation) would have
Table 2: Description of sample set
Number of women Details
Extraction MBR 150 Sister pairs where both had undergone caesarean section at a 
gestational length of more than 286 days
Excluded directly 2 One deceased and one emigrated
Excluded after interview 54 One or both sisters refused to participate
Added 10 Additional sisters or cousins
Total 104
Blood samples collected 83
Blood samples analyzed, Affymetrix 39 These women were included in the genetic analysis (NPL)
Blood samples analyzed, re-sequencing 68 These women were included in the re-sequencing of OXT and OXTR
Table 3: Clinical characteristics of all interviewed women (n = 104)
Characteristic Mean Range SD
Age 30.2 19.2-43,1 5.0
BMI 27.4 19.1-39.5 3.7
Gestational length 41 + 6 38 + 0 - 43 + 4
Time from start of delivery to parturition (h) 26:33 4:25 - 96:00
Birth weight (g) 3824 2360 - 5260 568Algovik et al. BMC Medical Genetics 2010, 11:105
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corresponded to and NPL-score of 1.98. Our best linkage
peak was located on chromosome 12p12 (NPL score
3.15), and other peaks with suggestive linkage were found
on chromosomes 3, 4, 6 and 20. Linkage results are sum-
marized in Table 6. The division into the subgroups with
certain, likely, unlikely and no dystocia did not increase
the significance of genetic analysis. Similarly, division of
data into subgroups according to geographical region did
not produce significant change to analysis results. Peak
regions contained several apoptosis-related factors, cal-
cium-calmodulin dependent kinases, and phospholipase
c-like genes, but we were most interested in oxytocin on
chromosome 20, oxytocin receptor on 3, endothelin con-
verting enzyme on 3 and endothelin receptor type A on 4.
We did not succeed in identifying any dystocia candidate
genes in the linkage peak regions on chromosomes 6, 10
and 12.
Re-sequencing of OXT and OXTR
Initially, we sequenced all OXT and OXTR exons includ-
ing splice sites and putative promoter regions in five indi-
viduals with dystocia and one control to detect common
variations. One known polymorphism was detected
within the OXT  locus, but did not differ in allele fre-
quency from that expected from dbSNP data. We were
unable to sequence exon 2 due to high (> 70%) GC con-
tent. Sixteen variations were identified within the OXTR
locus, of which four were novel and the remaining 12
were included in dbSNP with rs numbers. Eleven OXTR
polymorphisms were selected for sequencing in 68 dysto-
cia cases (Table 5) to assess their allele frequencies in
comparison with a historic reference group consisting of
107 women with characteristics described in Table 7.
OXTR  polymorphisms are summarized in Table 8. All
detected polymorphisms, including the three successfully
genotyped newly detected ones (rsOXTR_01, 02 and 04),
were observed to have population frequencies above 1%,
and without even suggestive evidence for association,
making it unlikely that they would be involved in risk of
dystocia.
Discussion
According to our knowledge, this is the first paper assess-
ing the genetic origin of dystocia through non-parametric
linkage analysis. There is strong suggestive evidence of
linkage at chromosome 12p12 and we found several pos-
sible genes in the areas of interest but none that struck as
being solely responsible for this condition. The re-
s e q u e n c i n g  o f  o x y t o c i n  ( OXT) and oxytocin receptor
(OXTR), both of which are obvious candidate genes, did
not allow us to identify any potential causal mutations.
However, it is possible that we have overseen regulatory
variants affecting gene expression, mRNA stability or
localization of protein product. It is also possible that we
have overlooked true candidate genes on regions showing
suggestive linkage on chromosomes 4, 6, 10 and 12. We
chose comparison with a healthy historic reference mate-
rial for the re-sequencing of OXT and OXTR. Evidently
this group differs from our cases regarding age, BMI, ges-
tational length and birth weight but we did not manage to
find any mutations. If we actually had found any muta-
tions a comparison with matched controls would of
course have been preferable.
The results of the present study may be explained in
different ways. One obvious weakness is that the pheno-
type of dystocia is not strictly defined due to clinical het-
erogeneity and its diagnosis depends both on patient
characteristics and the obstetric experience of the local
hospital staff. Thus, the use of the clinical entity dystocia
varies according to local preferences and traditions, and
institutions are likely to diagnose dystocia in a non-stan-
dardized manner. This is well illustrated in Sweden where
dystocia prevalence in different delivery wards differs
widely between 4 and 33 percent [23]. Since the study
design is retrospective and partly based on telephone
Table 4: Clinical characteristics for affected sib pairs included in the genetic analysis (NPL) (n = 39)
Characteristic Mean Range SD
Age 32.3 21.9-43.1 4.8
BMI 27.1 20.3-39.5 3.8
Gestational length 41 + 6 40 + 6- 43 + 1
Time from start of delivery to parturition (h) 28:01 6:00 - 96:00
Birth weight (g) 3928 2750 - 4850 454
Table 5: Clinical characteristics of the women included in 
the re-sequencing of OXT and OXTR (n = 68)
Characteristic Mean Range SD
Age 31.0 20.7-43.1 5.0
BMI 27.5 19.1-39.5 3.9
Gestational length 41 + 6 38 + 5- 43 + 3
Birth weight (g) 3886 2750 - 4850 477Algovik et al. BMC Medical Genetics 2010, 11:105
http://www.biomedcentral.com/1471-2350/11/105
Page 5 of 7
interviews there is a possibility of recall bias, but the
interviews were combined with a thorough review of the
medical charts. Traditionally dystocia is attributed to
three general causes, the three P's in obstetrics; power,
passenger and pelvis. With the present approach exclud-
ing fetal-maternal disproportion and maternal over-
weight we attempted to predominantly study the power
(uterine muscle activity) within this phenotype.
Although this may have led to the identification of a
more consistent group in regards to poor labour it might
also have introduced a certain degree of selection bias.
We cannot exclude the possibility that the linkage is in
fact to some other condition such as high birth weight or
post term pregnancy but since these conditions often are
related, the genetics of each might be quite complicated
to elucidate.
The present study is an example of a project where data
from several medical registers has been combined and
where we have been granted permission by the Institu-
tional Review Board to contact the patients directly for
obtaining biological samples. This is a quite unique
approach and it is notable that this approach was well
received by the patients. Only 15 women (10%) declined
to participate directly at the telephone interview and no
case of offending a woman by this direct approach was
encountered. On the contrary, the majority of women
were willing to donate blood samples without any com-
pensation. Thus, the direct approach appears feasible and
has great potential to increase the scientific value of med-
ical registers.
This study indicates that dystocia is a complex disease
that is probably not caused by a single locus disease allele.
Knowledge of the genetic architecture of complex dis-
eases is still incomplete and it is possible that the risk for
any common disease is dependent on a large number of
loci, each with a number of low frequency disease-predis-
posing alleles [24]. The study population included only a
limited sample size making it underpowered for associa-
tion analysis. Our results thus merely established that the
newly detected variants were polymorphisms (population
frequency > 1%) and adding more subjects would be nec-
essary to increase the opportunity to perform a well-pow-
ered genetic association analysis.
During evolution there is balance between mutation
and selection and since dystocia-causing mutations
would not be brought on to the next generation in the
absence of the possibility of caesarean section, there is
most likely genetic heterogeneity responsible for the phe-
notype. The disease-causing alleles can of course also be
p r o p a g a t e d  b y  m a l e  o f f s p r i n g ,  b u t  w e  h a v e  s o  f a r  n o t
studied any possible male phenotype.
S i n c e  t h e  o c c u r r e n c e  o f  d y s t o c i a  i s  l i k e l y  t o  i n v o l v e
allelic variations in several different loci we think that it
might be very cumbersome and costly to collect a large
enough sample set to reach significance in any single
locus with genome-wide linkage analysis. An alternative
and complimentary approach would be to focus on exten-
sive re-sequencing of candidate genes in affected individ-
uals and controls to assess genetic variability within
candidate loci and identify possible causal variants. We
Table 6: Linkage results
Chr Marker range Physical range NPL score Genomic P
20 rs2013961 - rs674110 2 - 4 Mbp 2.23 (3.7 Mbp) 0.97
12 rs1405608 - rs722918 20 - 62 Mbp 3.15 (51 Mbp) 0.21
10 rs726176 - rs1409317 97 - 121 Mbp 2.92 (115 Mbp) 0.37
6 rs1979541 - rs979515 159 - 165 Mbp 2.84 (164 Mbp) 0.43
4 rs723794 - rs1464452 147 - 157 Mbp 3.03 (154 Mbp) 0.28
3 rs1508722 - rs2358693, 7 - 22 Mbp, 2.43 (13 Mbp), 0.87
rs725318 - rs763342 179 - 189 Mbp 2.55 (185 Mbp) 0.74
Table 7: Clinical characteristics of the reference group (n = 107)
Characteristic Mean Range SD
Age 28.4 17.0-43.0 4.7
BMI 22.7 17.2-34.5 3.7
Gestational length 39 + 4 37 + 0-42 + 0
Birth weight (g) 3540 2560-4540 385Algovik et al. BMC Medical Genetics 2010, 11:105
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have focused on the maternal genotypes but during preg-
nancy it is probably of interest to take the genetics of the
child into account as well. For example, our study does
not assess whether dystocia risk is affected by the proper-
ties of the fetus, but this might be worthwhile to pursue
further.
Conclusions
In the overall assessment of a woman giving birth the
obstetrician might find the knowledge that epidemiologi-
cal studies have shown an increased risk of dystocia in a
primiparous woman if her mother or sister has experi-
enced the same problem to be useful. Our study indicates
that there actually might be a genetic background for dys-
tocia through a strong suggestive evidence of linkage at
chromosome 12p12 and also at 5 other loci that might be
of interest. We believe that larger studies including
patients with a well defined phenotype of dystocia might
lead to new insights into the aetiology and physiology of
this important condition.
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